Compare Cadila Healthcare with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs WOCKHARDT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES WOCKHARDT ZYDUS LIFESCIENCES/
WOCKHARDT
 
P/E (TTM) x 16.2 -54.0 - View Chart
P/BV x 2.9 1.2 242.3% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 ZYDUS LIFESCIENCES   WOCKHARDT
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-21
WOCKHARDT
Mar-21
ZYDUS LIFESCIENCES/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs509570 89.4%   
Low Rs259174 148.8%   
Sales per share (Unadj.) Rs147.5249.3 59.2%  
Earnings per share (Unadj.) Rs20.962.2 33.6%  
Cash flow per share (Unadj.) Rs28.084.4 33.1%  
Dividends per share (Unadj.) Rs3.500-  
Avg Dividend yield %0.90-  
Book value per share (Unadj.) Rs126.9302.3 42.0%  
Shares outstanding (eoy) m1,023.74110.78 924.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.61.5 174.5%   
Avg P/E ratio x18.46.0 307.4%  
P/CF ratio (eoy) x13.74.4 311.6%  
Price / Book Value ratio x3.01.2 246.0%  
Dividend payout %16.80-   
Avg Mkt Cap Rs m393,09241,188 954.4%   
No. of employees `000NANA-   
Total wages/salary Rs m22,5487,630 295.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m151,02227,620 546.8%  
Other income Rs m4491,534 29.3%   
Total revenues Rs m151,47129,155 519.5%   
Gross profit Rs m31,33512,575 249.2%  
Depreciation Rs m7,2482,460 294.6%   
Interest Rs m1,6882,491 67.8%   
Profit before tax Rs m22,8489,159 249.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4722,273 64.8%   
Profit after tax Rs m21,3766,886 310.4%  
Gross profit margin %20.745.5 45.6%  
Effective tax rate %6.424.8 26.0%   
Net profit margin %14.224.9 56.8%  
BALANCE SHEET DATA
Current assets Rs m87,16024,244 359.5%   
Current liabilities Rs m78,61331,182 252.1%   
Net working cap to sales %5.7-25.1 -22.5%  
Current ratio x1.10.8 142.6%  
Inventory Days Days3330 110.1%  
Debtors Days Days7612 623.3%  
Net fixed assets Rs m140,94349,508 284.7%   
Share capital Rs m1,024554 184.9%   
"Free" reserves Rs m128,89932,939 391.3%   
Net worth Rs m129,92333,492 387.9%   
Long term debt Rs m6,0955,029 121.2%   
Total assets Rs m228,10373,752 309.3%  
Interest coverage x14.54.7 310.8%   
Debt to equity ratio x00.2 31.2%  
Sales to assets ratio x0.70.4 176.8%   
Return on assets %10.112.7 79.5%  
Return on equity %16.520.6 80.0%  
Return on capital %18.030.2 59.6%  
Exports to sales %00-   
Imports to sales %10.51.8 583.9%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m15,911498 3,192.4%   
Fx inflow Rs m63,5351,009 6,296.2%   
Fx outflow Rs m15,911498 3,192.4%   
Net fx Rs m47,624511 9,325.2%   
CASH FLOW
From Operations Rs m32,930-2,873 -1,146.1%  
From Investments Rs m-7,22514,701 -49.1%  
From Financial Activity Rs m-25,489-11,708 217.7%  
Net Cashflow Rs m-905129 -701.0%  

Share Holding

Indian Promoters % 74.9 67.1 111.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.4 3.0 518.1%  
FIIs % 2.5 2.9 87.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.1 32.9 76.4%  
Shareholders   408,017 172,460 236.6%  
Pledged promoter(s) holding % 0.0 43.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   CIPLA    SUN PHARMA    LUPIN    DR. REDDYS LAB    AUROBINDO PHARMA    



Today's Market

Sensex Ends 236 Points Lower, Nifty Falls Below 16,150; IT & FMCG Stocks Witness Selling(Closing)

Indian share markets ended on a negative note today as global cues remained weak.

Related Views on News

Cadila Healthcare Reports 73% Rise in Profits (Views On News)

May 28, 2021

A look into the company's quarter four financial performance.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ZYDUS LIFESCIENCES SHARE PRICE


May 24, 2022 03:31 PM

TRACK ZYDUS LIFESCIENCES

  • Track your investment in ZYDUS LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZYDUS LIFESCIENCES

ZYDUS LIFESCIENCES 8-QTR ANALYSIS

COMPARE ZYDUS LIFESCIENCES WITH

MARKET STATS